SKYCLARYS

Reata Pharmaceuticals, Inc.

Application Filed: 2019-09-03
Trademark Application Details
Trademark Logo SKYCLARYS

Mark For: SKYCLARYS® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy. [all]

Status

2023-02-28 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88601903
Registration Number1536012
Mark Literal ElementsSKYCLARYS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2022-08-08
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCynthia Johnson Walden
Attorney Docket Number441050006001

Timeline

2019-09-03Application Filed
2019-09-13Location: NEW APPLICATION PROCESSING
2019-09-13Status: Live/Pending
2019-09-14Transaction Date
2020-01-07Published
2022-08-08Location: INTENT TO USE SECTION
2022-08-08Status: A fifth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Reata Pharmaceuticals, Inc.
Address2801 Gateway Drive, Suite 150 Irving, TEXAS UNITED STATES 75063
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

CYNTHIA JOHNSON WALDEN
FISH & RICHARDSON P.C.
P.O. BOX 1022
MINNEAPOLIS, MN 55440-1022

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy
GS0051pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-08-09
SOU EXTENSION 5 GRANTED2022-08-0871906
CASE ASSIGNED TO INTENT TO USE PARALEGAL2022-08-0871906
TEAS EXTENSION RECEIVED2022-07-27
SOU EXTENSION 5 FILED2022-07-2771906
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-03-04
TEAS EXTENSION RECEIVED2022-03-02
SOU EXTENSION 4 GRANTED2022-03-0298765
SOU EXTENSION 4 FILED2022-03-0298765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-08-26
TEAS EXTENSION RECEIVED2021-08-24
SOU EXTENSION 3 GRANTED2021-08-2498765
SOU EXTENSION 3 FILED2021-08-2498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-03-04
TEAS EXTENSION RECEIVED2021-03-02
SOU EXTENSION 2 GRANTED2021-03-0298765
SOU EXTENSION 2 FILED2021-03-0298765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-08-15
TEAS EXTENSION RECEIVED2020-08-13
SOU EXTENSION 1 GRANTED2020-08-1398765
SOU EXTENSION 1 FILED2020-08-1398765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-03-03
PUBLISHED FOR OPPOSITION2020-01-07
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-01-07
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-12-18
ASSIGNED TO EXAMINER2019-12-0593661
APPROVED FOR PUB - PRINCIPAL REGISTER2019-12-05
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-09-13
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2019-09-13
NEW APPLICATION ENTERED IN TRAM2019-09-06
NEW APPLICATION ENTERED2019-09-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed